link to unsubscribehttp://www.aweber.com/z/r/?jMxMLBzM7LQs7OwszBxsnLRGtIyMDAzMjAws
Hello All,
Great week everyone !!!
Monday's alert was up 14% at the high and Thursdays alert was up
81% at it's high !!
Congratulations to all those that booked profits.
Thank you to everyone who sent in kind words and let us know about
your success.
Everyone make sure to always keep the Trading Strategies in mind.
If you follow them there are plenty of profits to be had.
Let's keep the profits rolling with our alert for Monday.
This is another stock that not many investors know about yet.
We also know this company is the subject of an exposure campaign so
lots of people are going to find out about this one in a hurry.
It's average daily volume is only about 50,000 shares.
We all saw what can happen when a low average daily volume stock
gets attention from investors just finding out about it.
Our guess is Monday the stock will trade much more than its average
daily volume so get ready to take advantage of it.
Thats why we specialize in these stocks. They can really move when
attention gets focused on them.
Let's get to it!
Monday's alert is exciting for several reasons.
It is a biotechnology company, and for some reason biotech stocks
seem to do well in the OTC market.
Its proprietary product may treat both Parkinson's disease
and Diabetes!
Parkinson's has combined direct and indirect cost of $25
Billion a year.
Diabetes has a combined direct and indirect cost of $218
Billion a year.
These are HUGE markets. When investors hear about this they could
be very excited !!
Our alert for Monday is Amarantus Biosciences, Inc., AMBS, and the
stock closed Friday at 30 cents.
Please begin your research here www.amarantus.com; and here
http://finance.yahoo.com/q?s=AMBS.OB&ql=0
Here's some information to get you started:
AMBS is a biotechnology company engaged in the research and
development of first-in-class disease-modifying treatments that
address the underlying cause of cell death, known as apoptosis,
associated with a wide range of diseases.
AMBS's most advanced product candidate is called MANF and is a
therapeutic protein.
This protien offers the promise of safely and effectively
protecting dopamine producing neurons from death and rejuvenating
dying cells to ultimately stop the progress of Parkinson's disease
and restore normal function to patients.
AMBS received a research grant from The Michael J. Fox Foundation
for Parkinson's Research.
As many as one million Americans and up to 10 million people
worldwide live with Parkinson's disease.
AMBS's MANF treatment is not only potentially helpful in treating
Parkinsons, but Diabetes as well!
AMBS announced a joint research project with Generex Biotechnology,
Inc., a Toronto-based biotechnology company developing an
oral-insulin spray technology known as Oral-lyn(TM) currently in
Phase III clinical trials
AMBS recently announced that the companies have selected the
development of a MANF-based therapeutic for the treatment of the
beta cell destruction at the root of diabetes as the second program
for their joint research collaboration announced on May 31, 2011.
AMBS's first collaboration program announced on June 8, 2011 is for
the development of a MANF-based diagnostic test to identify a
sub-population at risk of developing Type 1 or Type 2 diabetes.
In America, diabetes affects 25.8 million people of all ages,
that's 8.3 percent of the U.S. population!
CNN estimated in 2009 that the direct medical cost of treating
diabetes will rise from $113 billion annually to $336 billion over
25 years.
Diabetes treatment is a huge market, and if AMBS's joint research
can produce an effective treatment method you can imagine how HUGE
that would be.
Again, when deciding if you want to trade any stock, you must think
"will other investors be excited when they learn about this
company".
Let's recap so you can decide for yourself.
1) Bio Tech company. There are 100 examples of biotech companies
that went from pennys to dollars overnight. All they need to do is
come out with a press release and say they found the cure to
something and it's all over.
2) Low average daily volume. This means as new investors find out
about AMBS if there are more buyers than sellers the stock should
move !!
3) Great story with lots of potential in HUGE markets!!
We think as the awareness campaign rolls out and lots of people
find out about this stock they will get excited about it. This
excitement turns creates buying and buying makes stock prices go up.
Get yourself in a position to profit from any price gains.
AMBS belongs on your watchlist for Monday.
As always, do your own research, always use stop loss orders to
protect yourself, and book your profits when in a position to do so.
Good Trading,
OTCStockExchange
If you do not trade with a broker that allows stops GET ONE.
ChoiceTrades does allow stops and they only charge $5 commissions
on OTC stocks. Open an account by following this link.
http://wfwsconsulting.com/choicetrades
We can be found on Facebook at
http://www.facebook.com/OTCStockExchange
IMPORTANT NOTICE AND DISCLAIMER
WFWS Consulting Inc. is an information and marketing firm and is
not a financial analyst, investment advisor or broker/dealer. We
are in the business of marketing and advertising companies to
generate exposure of them by sending alerts to our subscribers for
monetary compensation.
The content of this e-mail sent by WFWS Consulting Inc. is paid
advertising and does not purport to provide an analysis of the
featured company's financial position, operations or prospects.
Because this advertisement has not been prepared with any one
individuals financial condition or investment goals in mind it is
not to be construed as a recommendation or solicitation by WFWS
Consulting Inc. to buy or sell any security.
WFWS Consulting Inc. has been paid $20,000 cash by Raven Consulting
LLC. for the purpose of increasing public awareness of AMBS.
WFWS has not investigated the background of the hiring company.
Anyone viewing this newsletter should assume the hiring party or
affiliates of the hiring party own shares of the company mentioned
which they plan to liquidate, further understanding that the
liquidation of those shares may or may not negatively impact the
share price.
Viewers of this newsletter should understand that trading activity
and stock prices in many if not all cases tend to increase during
the advertisement campaigns of the profiled companies and in many
if not all cases tend to decrease thereafter. This tends to create
above average volatility and price movements in the profiled
company's stock during the advertisement campaign that viewers
should take into consideration at all times. Campaigns vary in
length, and many are for short periods of time, typically less than
a week.
Investing in securities is highly speculative and carries a great
deal of risk, especially as to newer companies with comparatively
short operating histories and limited earnings. You may lose your
entire investment. If you cannot afford to lose your entire
investment do NOT invest in penny stocks.
WFWS has no relationship with ChoiceTrades.com other than a
one-time referral fee if a reader clicks on our link and becomes a
client of ChoiceTrades.com. WFWS relies upon the accounting of such
fees furnished to it by ChoiceTrades.com but has no access to the
identity or account information of any such person(s).
WFWS Consulting Inc. nor any of its officers or principals or
affiliates (as defined in the Securities Act of thirty three, as
amended, and Rule 501(b) promulgated thereunder) will ever own or
beneficially own any securities of any company mentioned in this
email. We are advertisers, not investors or traders.
This advertisement is based entirely upon information gathered from
public information and third party websites. Although the
information contained in this e-mail is believed to be reliable,
WFWS Consulting Inc. makes no warranties as to the accuracy of the
content of this e-mail, expressly disclaims and accepts no
liability for how readers may choose to utilize the content of this
e-mail. Readers are strongly urged to independently verify all
statements made in this advertisement and to perform their own due
diligence on this or any other advertised company, including but
not limited to consulting with a qualified investment professional,
reviewing the publicly available financial statements of, and other
information about these featured companies and verifying that an
investment in that company is appropriate and suitable for you.
Featured companies are traded on the OTC Bulletin Board or Pink
Sheets and their stock is registered under the Securities Act of
thirty three, as amended, and its periodic and other reports filed
under the Securities Exchange Act of thirty four, as amended, are
publicly available from the Securities and Exchange Commission at
its website at http://www.sec.gov, which also contains general
investor information about publicly-traded companies, advice to
investors and other investor resources. Other investor resources
are available from the Financial Industry Regulatory Authority
through its website at http://www.finra.org.
Many states have established rules requiring approval by the state
securities administrator to permit sales of a security to its
residents. Check with the North American Securities Administrators
Association through its website at http://www.nasaa.org or call
your state securities administrator to determine whether a
particular security may be purchased by you as a resident of your
state. Many companies have filed information with state securities
regulators and many companies will supply prospective investors
with additional information upon request.
This advertisement contains forward-looking statements about the
featured company its business and prospects. Such forward-looking
statements are within the meaning of Section Twenty Seven A of the
Securities Act of thirty three, as amended, and Section Twenty One
E of the Securities Exchange Act of thirty four, as amended, and
are intended to be covered by the safe harbor provisions created by
these laws. Where a featured company expresses or implies an
expectation or belief as to future events or results, such
expectation or belief is believed to have a reasonable basis.
However, forward-looking statements are subject to risks,
uncertainties and other factors that could cause actual results to
differ materially from future results expressed, projected or
implied by such forward-looking statements.
WFWS Consulting Inc, 1900 Empire Blvd, #212, Webster, New york 14580, USA
To unsubscribe or change subscriber options visit:
http://www.aweber.com/z/r/?jMxMLBzM7LQs7OwszBxsnLRGtIyMDAzMjAws
